- Home
- GIFT vs CVM Comparison
GIFT vs CVM Comparison
Compare GIFT & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIFT
- CVM
- Stock Information
- Founded
- GIFT 1999
- CVM 1983
- Country
- GIFT United States
- CVM United States
- Employees
- GIFT N/A
- CVM N/A
- Industry
- GIFT Catalog/Specialty Distribution
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GIFT Consumer Discretionary
- CVM Health Care
- Exchange
- GIFT Nasdaq
- CVM Nasdaq
- Market Cap
- GIFT 38.5M
- CVM 40.1M
- IPO Year
- GIFT N/A
- CVM 1987
- Fundamental
- Price
- GIFT $1.38
- CVM $0.40
- Analyst Decision
- GIFT Strong Buy
- CVM
- Analyst Count
- GIFT 1
- CVM 0
- Target Price
- GIFT $4.00
- CVM N/A
- AVG Volume (30 Days)
- GIFT 111.4K
- CVM 1.2M
- Earning Date
- GIFT 03-04-2025
- CVM 02-14-2025
- Dividend Yield
- GIFT N/A
- CVM N/A
- EPS Growth
- GIFT N/A
- CVM N/A
- EPS
- GIFT N/A
- CVM N/A
- Revenue
- GIFT $86,439,146.00
- CVM N/A
- Revenue This Year
- GIFT $3.23
- CVM N/A
- Revenue Next Year
- GIFT $25.39
- CVM N/A
- P/E Ratio
- GIFT N/A
- CVM N/A
- Revenue Growth
- GIFT N/A
- CVM N/A
- 52 Week Low
- GIFT $0.50
- CVM $0.33
- 52 Week High
- GIFT $4.50
- CVM $2.50
- Technical
- Relative Strength Index (RSI)
- GIFT N/A
- CVM 45.54
- Support Level
- GIFT N/A
- CVM $0.39
- Resistance Level
- GIFT N/A
- CVM $0.68
- Average True Range (ATR)
- GIFT 0.00
- CVM 0.06
- MACD
- GIFT 0.00
- CVM 0.01
- Stochastic Oscillator
- GIFT 0.00
- CVM 18.86
About GIFT RDE Inc. Common Stock
Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.